Literature DB >> 16698764

Is the periodic repetition of a coagulation check necessary during anti-hepatitis C virus therapy?

F Capra, N Nicolini, M Franchini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698764      PMCID: PMC1856217          DOI: 10.1136/gut.2006.091496

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Inhibitors against factor VIII associated with the use of interferon-alpha and fludarabine.

Authors:  S Sallah; J Y Wan
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

Review 2.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

3.  Factor VIII inhibitor associated with peginterferon.

Authors:  C Herman; L Boggio; D Green
Journal:  Haemophilia       Date:  2005-07       Impact factor: 4.287

Review 4.  Acquired hemophilia A: a concise review.

Authors:  Massimo Franchini; Giorgio Gandini; Tiziana Di Paolantonio; Guglielmo Mariani
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

5.  Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy.

Authors:  R B Stricker; B Barlogie; D D Kiprov
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

6.  Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A.

Authors:  E C Castenskiold; B T Colvin; S M Kelsey
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

7.  Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-alpha: a case report.

Authors:  Zwi A Schreiber; Norbert Bräu
Journal:  Am J Hematol       Date:  2005-12       Impact factor: 10.047

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.